A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy

References

• Diestelhort JS, Hughes GM. Open-angle glaucoma. Am Fam Phys 2003;67:1937–44
   PubMed Web of Science ®Google Scholar
• Hattenhauer MG, Johnson DH, Ing HH, et al. The probability of blindness from open-angle glaucoma. Ophthalmology 1998;105:2099–104
   PubMed Web of Science ®Google Scholar
• Broman AT, Quigley HA. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:253–4
   PubMed Web of Science ®Google Scholar
• Ramrattan RS, Wolfs RC, Panda-Jonas S, et al. Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: the Rotterdam Study. Arch Ophthalmol 2001;119:1788–94
   Google Scholar
• Owen CG, Carey IM, De Wilde S, et al. The epidemiology of medical treatment for glaucoma and ocular hypertension in the United Kingdom: 1994 to 2003. Br J Ophthalmol 2006;90:861–8
   PubMed Web of Science ®Google Scholar
• Lee DA, Higginbotham EJ. Glaucoma and its treatment: a review. Am J Health Syst Pharm 2005;62:691–9
   PubMed Web of Science ®Google Scholar
• van der Valk R, Webers CA, Schouten JS, et al. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 2005;112:1177–85
   PubMed Web of Science ®Google Scholar
• Hedman K, Alm A. A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol. Eur J Ophthalmol 2000;10:95–104
   PubMed Web of Science ®Google Scholar
• Zhang WY, Po AL, Dua HS, Azuara-Blanco A. Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. Br J Ophthalmol 2001;85:983–90
   Google Scholar
• Einarson TR, Kulin NA, Tingey D, Iskedjian M. Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma. Clin Ther 2000;22:1502–15
   PubMed Web of Science ®Google Scholar
• Denis P, Berdeaux G. Variations nycthémérales de la pression intra-oculaire et décisions thérapeutiques: interprétation des résultats d’essais cliniques a partir d’un modèle statistique [Circadian rhythm variations of intra-ocular pressure and therapeutic decisions: interpretation of clinical results based on statistical model]. J Fr Ophtalmol 2004;27:2S39–2S43
   Google Scholar
• Laird NM, Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care 1990;6:5–30
   PubMedGoogle Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50: 1088–101
   PubMed Web of Science ®Google Scholar
• Egger M, Davey, Smith G, et al. Bias in meta-analysis detected by a simple, graphical test. Br Med J 1997;315:629–34
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000;130:429–40
   Google Scholar
• Guevara JP, Berlin JA, Wolf FM. Meta-analytic methods for pooling rates when follow-up duration varies: a case study. BMC Med Res Methodol 2004;4: 17
   Google Scholar
• Vidal : le dictionnaire. Ed. du Vidal, Paris, 2006
   Google Scholar
• Netland PA, Landry T, Sullivan K, et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 2001;132:472–84
   PubMed Web of Science ®Google Scholar
• Cellini M, Caramazza R, Bonsanto D, et al. Prostaglandin analogs and blood-aqueous barrier integrity: a flare cell meter study. Ophthalmologica 2004;218:312–7
   PubMed Web of Science ®Google Scholar
• DuBiner H, Cooke D, Dirks M, et al. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Surv Ophthalmol 2001;45: S353–S360
   PubMed Web of Science ®Google Scholar
• Walters TR, DuBiner HB, Carpenter SP, et al.; Bimatoprost Circadian IOP Study Group. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial. Surv Ophthalmol 2004;49:S26–S35
   Google Scholar
• Cantor LB, Wu Dunn D, Cortes A, et al. Ocular hypotensive efficacy of bimatoprost 0.03% and travoprost 0.004% in patients with glaucoma or ocular hypertension. Surv Ophthalmol 2004;49:S12–S18
   Google Scholar
• Parrish RK, Palmberg P, Sheu WP, et al. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003;135:688–703
   PubMed Web of Science ®Google Scholar
• DuBiner HB, Sircy MD, Landry T, et al. Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure. Clin Ther 2004;26:84–91
   PubMed Web of Science ®Google Scholar
• Noecker RS, Dirks MS, Choplin NT, et al.; Bimatoprost/ Latanoprost-Study-Group. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 2003;135:55–63
   Google Scholar
• Noecker RJ, Earl ML, Mundorf T, et al. Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension. Adv Ther 2003;20: 121–8
   Google Scholar
• European Medicines Agency. Ganfort. European Public Assessment Report. http://www.emea.eu.int/humandocs/Humans/ EPAR/ganfort/ganfort.htm
   Google Scholar
• Bouyer J, Hémon D, Cordier S, et al. Epidémiologie, principes et méthodes quantitatives.1993 Les editions INSERM
   Google Scholar